Atrial Fibrillation Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People whose doctor has decided they should be treated with the FARAPULSE™ Pulsed Field Ablation system for heart tissue ablation, in line with the hospital's standard care practices
- People who are willing and able to give their informed consent to take part
- People who are willing and able to attend all required study visits and tests at an approved study centre
- People who are 18 years of age or older
Who may not be able to join:
- People who have a baffle or patch between the upper chambers of the heart
- People who have a known or suspected benign tumour in the heart called an atrial myxoma
- People who have had a heart attack within the 14 days before enrolling in the study
- People who have had a stroke within the 30 days before enrolling in the study
- People who cannot tolerate blood-thinning medication (anticoagulation therapy)
- People who have an active infection affecting the whole body
- People who have a known blood clot in the upper chambers of the heart
- People who are known to have difficulty with access to their blood vessels for procedures
- People who are pregnant or planning to become pregnant
- People whose atrial fibrillation is caused by an imbalance of salts in the blood, a thyroid condition, alcohol use, or other reversible or non-heart-related causes
- People who have any artificial heart valve, ring, or repair, including a procedure called balloon aortic valvuloplasty
- People for whom their doctor considers it unsafe to have a catheter inserted or moved inside the heart chambers — for example, due to recent heart surgery, recent unstable chest pain, or certain heart conditions present from birth that increase the risks of the procedure
- People whose life expectancy is one year or less, in the opinion of the study investigator
- People who are currently enrolled in another research study or registry that would interfere with this study — though exceptions may apply for certain government-required registries or observation-only registries with no associated treatments (each case must be reviewed by the study sponsor to determine whether participation is permitted)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Min Tang, Dr, Chinese Academy of Medical Sciences, Fuwai Hospital
Phone: 15810430945
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Failure-free rate; Device-or procedure-related SAEs:; Procedure- and device related adverse events
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.